Search

everythinglearnresearchcommunity

for

Search:↓

Blocking androgen activity in newborn rats affects body weight and appetite-related hormones differently in males and females.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Baricitinib may effectively treat oral lichen planus.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

JAK inhibitors, PRP, and exosomes show promise for hair regrowth in Alopecia Areata.

OR-101 shows promise for treating alopecia areata by improving hair growth.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

JAK inhibitors partially restore scalp bacteria balance in alopecia areata patients.

Oral Janus kinase inhibitors may be an effective treatment option for lichen planopilaris with some risk of increased cholesterol and liver enzyme levels.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

A man developed oral hairy leukoplakia while on baricitinib, a medication for alopecia and arthritis, and doctors should watch for such side effects.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

Farudodstat may effectively treat alopecia areata by protecting hair follicles without harmful effects.

Blocking casein kinase 1 in skin cells can help melanocyte precursors move better, potentially helping with conditions like vitiligo or gray hair.

Blocking a key energy pathway in human hair follicles can trigger stress responses that stop cell growth.

Two new IRAK4-inhibitors effectively reduced skin inflammation and immune response markers in healthy volunteers.

JAK inhibitors help hair growth by boosting beta-catenin activity in hair root cells.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

JAK inhibitors help treat alopecia areata but have high recurrence after stopping.

Short-term treatment with ROCKi increases skin cell growth without changing stem cell features.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Deleting MPZL3 increases skin oil production and reduces body fat.

JAK inhibitors like baricitinib are a new FDA-approved treatment for alopecia areata, but safety data is incomplete.

Stress-related hair loss was reversed with a special medication.

Blocking DPP4 can help activate hair growth and improve hair regeneration.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.